Literature DB >> 29598933

The Effect of Door-to-Diuretic Time on Clinical Outcomes in Patients With Acute Heart Failure.

Jin Joo Park1, Sun-Hwa Kim1, Il-Young Oh1, Dong-Ju Choi2, Hyun-Ah Park3, Hyun-Jai Cho4, Hae-Young Lee4, Jae-Yeong Cho5, Kye Hun Kim5, Jung-Woo Son6, Byung-Su Yoo6, Jaewon Oh7, Seok-Min Kang7, Sang Hong Baek8, Ga Yeon Lee9, Jin Oh Choi9, Eun-Seok Jeon9, Sang Eun Lee10, Jae-Joong Kim10, Ju-Hee Lee11, Myeong-Chan Cho11, Se Yong Jang12, Shung Chull Chae12, Byung-Hee Oh4.   

Abstract

OBJECTIVES: This study sought to examine the impact of door-to-diuretic (D2D) time on mortality in patients with acute heart failure (AHF) who were presenting to an emergency department (ED).
BACKGROUND: Most patients with AHF present with congestion. Early decongestion with diuretic agents could improve their clinical outcomes.
METHODS: The Korea Acute Heart Failure registry enrolled 5,625 consecutive patients hospitalized for AHF. For this analysis, the study included patients who received intravenous diuretic agents within 24 h after ED arrival. Early and delayed groups were defined as D2D time ≤60 min and D2D time >60 min, respectively. The primary outcomes were in-hospital death and post-discharge death at 1 month and 1 year on the basis of D2D time.
RESULTS: A total of 2,761 patients met the inclusion criteria. The median D2D time was 128 min (interquartile range: 63 to 243 min), and 663 (24%) patients belonged to the early group. The baseline characteristics were similar between the groups. The rate of in-hospital death did not differ between the groups (5.0% vs. 5.1%; p > 0.999), nor did the post-discharge 1-month (4.0% vs. 3.0%; log-rank p = 0.246) and 1-year (20.6% vs. 19.3%; log-rank p = 0.458) mortality rates. Get With the Guidelines-Heart Failure risk score was calculated for each patient. In multivariate analyses with adjustment for Get With the Guidelines-Heart Failure risk score and other significant clinical covariates and propensity-matched analyses, D2D time was not associated with clinical outcomes.
CONCLUSIONS: The D2D time was not associated with clinical outcomes in a large prospective cohort of patients with AHF who were presenting to an ED. (Registry [Prospective Cohort] for Heart Failure in Korea [KorAHF]; NCT01389843).
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  acute heart failure; door-to-diuretic time; outcomes

Mesh:

Substances:

Year:  2018        PMID: 29598933     DOI: 10.1016/j.jchf.2017.12.017

Source DB:  PubMed          Journal:  JACC Heart Fail        ISSN: 2213-1779            Impact factor:   12.035


  8 in total

Review 1.  Paradigm Shifts of Heart Failure Therapy: Do We Need Another Paradigm?

Authors:  Hae-Young Lee; Byung-Hee Oh
Journal:  Int J Heart Fail       Date:  2020-04-06

2.  The FAST-FURO study: effect of very early administration of intravenous furosemide in the prehospital setting to patients with acute heart failure attending the emergency department.

Authors:  Òscar Miró; Pia Harjola; Xavier Rossello; Víctor Gil; Javier Jacob; Pere Llorens; Francisco Javier Martín-Sánchez; Pablo Herrero; Gemma Martínez-Nadal; Sira Aguiló; María Luisa López-Grima; Marta Fuentes; José María Álvarez Pérez; Esther Rodríguez-Adrada; María Mir; Josep Tost; Lluís Llauger; Frank Ruschitzka; Veli-Pekka Harjola; Wilfried Mullens; Josep Masip; Ovidiu Chioncel; W Frank Peacock; Christian Müller; Alexandre Mebazaa
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2021-06-30

3.  Inferior vena cava ultrasound in acute decompensated heart failure: design rationale of the CAVA-ADHF-DZHK10 trial.

Authors:  Alexander Jobs; Reinhard Vonthein; Inke R König; Jane Schäfer; Matthias Nauck; Svenja Haag; Carlo Federico Fichera; Thomas Stiermaier; Jakob Ledwoch; Alisa Schneider; Miroslava Valentova; Stephan von Haehling; Stefan Störk; Dirk Westermann; Tobias Lenz; Natalie Arnold; Frank Edelmann; Philipp Seppelt; Stephan Felix; Matthias Lutz; Felix Hedwig; Martin Borggrefe; Clemens Scherer; Steffen Desch; Holger Thiele
Journal:  ESC Heart Fail       Date:  2020-01-28

4.  Pre-hospital management protocols and perceived difficulty in diagnosing acute heart failure.

Authors:  Pia Harjola; Òscar Miró; Francisco J Martín-Sánchez; Xavier Escalada; Yonathan Freund; Andrea Penaloza; Michael Christ; David C Cone; Said Laribi; Markku Kuisma; Tuukka Tarvasmäki; Veli-Pekka Harjola
Journal:  ESC Heart Fail       Date:  2019-11-08

5.  The Impact of Door to Diuretic Time in Acute Heart Failure on Hospital Length of Stay and In-Patient Mortality.

Authors:  Arshad Muhammad Iqbal; Sohaib K Mohammed; Nida Zubair; Ateeq Mubarik; Adnan Ahmed; Syed Farrukh Jamal; Syed Moin Hassan; Furqan Haq; Salman Muddassir
Journal:  Cureus       Date:  2021-01-16

Review 6.  'Time is prognosis' in heart failure: time-to-treatment initiation as a modifiable risk factor.

Authors:  Amr Abdin; Stefan D Anker; Javed Butler; Andrew J Stewart Coats; Ingrid Kindermann; Mitja Lainscak; Lars H Lund; Marco Metra; Wilfried Mullens; Giuseppe Rosano; Jonathan Slawik; Jan Wintrich; Michael Böhm
Journal:  ESC Heart Fail       Date:  2021-10-16

7.  Impact of adjunctive tolvaptan on sympathetic activity in acute heart failure with preserved ejection fraction.

Authors:  Shunsuke Tamaki; Takahisa Yamada; Takashi Morita; Yoshio Furukawa; Masato Kawasaki; Atsushi Kikuchi; Tsutomu Kawai; Masahiro Seo; Makoto Abe; Jun Nakamura; Kyoko Yamamoto; Kiyomi Kayama; Masatsugu Kawahira; Kazuya Tanabe; Kunpei Ueda; Takanari Kimura; Daisuke Sakamoto; Yuto Tamura; Takeshi Fujita; Masatake Fukunami
Journal:  ESC Heart Fail       Date:  2020-04-03

Review 8.  Time-sensitive approach in the management of acute heart failure.

Authors:  Yasuyuki Shiraishi; Masataka Kawana; Jun Nakata; Naoki Sato; Keiichi Fukuda; Shun Kohsaka
Journal:  ESC Heart Fail       Date:  2020-12-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.